ResearcherNational and Kapodistrian University of AthensNo recent work listed

Gregory P. Kouraklis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9092-5346; OpenAlex author ID A5017462015. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nikolaos Garmpis · 2 shared papers, 2015–2022 · strength 0.17
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736 ↗
- Paper Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. PMID 26026072 ↗
Christos Damaskos · 2 shared papers, 2015–2022 · strength 0.17
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736 ↗
- Paper Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. PMID 26026072 ↗
Panagiotis Sarantis · 1 shared paper, 2022 · strength 0.12
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736 ↗
Efstathios Antoniou · 1 shared paper, 2022 · strength 0.12
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736 ↗
Evangelos Koustas · 1 shared paper, 2022 · strength 0.12
- Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.